Rufinamide Suspension
Product Images NDC 68180-797

14 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 68180-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 01)

Description (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 01)
Chemical structure diagram of Rufinamide showing its molecular framework with rings and functional groups including fluorine atoms and an amide group.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 02)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 02)
An instructional diagram showing the components included with Rufinamide 40 mg/mL oral suspension, consisting of a bottle, a box, a bottle adapter, and two syringes for dosing.*
FDA Label Image

B (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 03)

B (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 03)
An instructional illustration showing a hand holding a bottle of Rufinamide oral suspension with an arrow indicating to shake the bottle well before use. The image emphasizes proper handling of the 40 mg/mL suspension form by Lupin Pharmaceuticals, Inc.*
FDA Label Image

C (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 04)

C (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 04)
An illustration depicting a bottle adapter with labeled parts. The diagram shows a cylindrical object with multiple ridges and a central hole, identified as a bottle adapter.*
FDA Label Image

D (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 05)

D (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 05)
An instructional illustration shows a hand holding the neck of a bottle with an arrow pointing downward, indicating how to press down on the bottle cap for opening or closing.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 06)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 06)
An instructional illustration showing an oral syringe with measurement markings from 1 mL to 20 mL, highlighting the 15 mL mark. The syringe is labeled with a 'plunger' and is intended for dosing of Rufinamide oral suspension.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 07)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 07)
Illustration showing a hand holding a measuring syringe above a bottle, indicating the syringe is being inserted into the bottle for medication measurement or withdrawal, relevant to oral suspension dosing.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 08)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 08)
An instructional illustration showing a hand holding a syringe filled with liquid medication marked in milliliters from 0 to 20 mL, indicating how to draw or dispense the oral suspension. An arrow points downward, suggesting the direction of plunger movement.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 09)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 09)
Instructional illustration showing a close-up of a hand measuring the liquid level in an oral syringe. The text indicates to measure to the yellow end of the plunger, demonstrating how to accurately draw and measure the suspension dose.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 10)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 10)
An instructional black-and-white illustration showing a person administering oral suspension medication to a child using a syringe. The syringe is positioned near the child's mouth for liquid delivery.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 11)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 11)
Instructional illustration showing the use of a dosing syringe for oral suspension. The left panel depicts a hand drawing liquid into the syringe from a cup. The right panel shows liquid being dispensed from the syringe downward, presumably for administration.*
FDA Label Image

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 12)

Image (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 12)
An instructional line drawing showing a hand gripping the cap of a bottle, demonstrating how to open it by turning or pulling the cap. This relates to the oral suspension dosage form of Rufinamide 40 mg/mL by Lupin Pharmaceuticals, Inc.*
FDA Label Image

Label (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 13)

Label (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 13)
Label for Rufinamide Oral Suspension 40 mg/mL, 460 mL, by Lupin Pharmaceuticals, Inc. The label includes the NDC 68180-797-01 and provides storage instructions, dosage information note, and manufacturer details. It also contains a QR code, barcode, and a designated space for lot number and expiration date.*
FDA Label Image

Label (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 14)

Label (C0d2c9e4 Ab01 4809 9f1a 9ad4263d0785 14)
Label for Rufinamide Oral Suspension 40 mg/mL, an oral suspension liquid supplied with two 20 mL syringes. The label states it is orange flavored and for oral administration only. It shows a 460 mL bottle size, manufactured for Lupin Pharmaceuticals, Inc., Baltimore, and manufactured by Lupin Limited, India. Includes directions to dispense with medication guide and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.